Essential Health Screening Tests for Women

This comprehensive test is designed to detect various types of worms and amoebas that cause infections in women. It includes identifying liver flukes, trichinella, and roundworms commonly found in raw foods, as well as other parasites present in contaminated food or water sources, such as toxocara from dogs and cats.

Women will be tested for IgG and IgM antibodies to determine whether the infection is recent or has occurred in the past. These test indicators are invaluable for infection assessment and treatment.

Hepatitis B, C and A are common viral infections among women. Hepatitis B and C viruses can enter the body through blood, sexual contact, or unsterilized medical instruments, while hepatitis A is primarily transmitted via contaminated food sources.

Hepatitis test is essential for women, especially pregnant women as hepatitis B and C can be transmitted from mother to child. Early screening enables better health management and timely medical intervention, aiding in preventing serious health complications.

Fever is a common symptom of various viral and bacterial infections, such as influenza, malaria or dengue fever. These infections can lead to serious health issues if not treated promptly, particularly in pregnant women. Testing for fever-related infections enables screening for multiple pathogens, supporting accurate diagnosis and effective treatment.

H. pylori is a leading cause of peptic ulcers in women, often presenting symptoms such as abdominal pain, burning sensation, nausea, vomiting, bloating, and blood in the stool. However, some individuals may remain asymptomatic. The H. pylori test is essential for early detection, allowing for effective treatment to prevent serious complications, such as gastric cancer.

This critical testing panel provides an overall assessment of key organ systems, including the heart, liver, kidneys and thyroid. Test indicators can reveal functional disorders or potential abnormalities within these organs.

Comprehensive testing allows for timely intervention, helping to prevent diseases or manage chronic conditions such as diabetes, cardiovascular issues, kidney failure and thyroid disorders.

This test measures indicators such as cholesterol, apolipoprotein, and high-sensitivity Troponin to evaluate heart function and identify issues related to atherosclerosis, myocardial infarction and other serious cardiovascular conditions. Additionally, the test includes Homocysteine measurement to assess risk factors for future cardiovascular disease.

This test examines indicators such as liver enzymes, bilirubin levels and albumin to enable early detection of liver damage. It helps identify conditions such as hepatitis, liver infections, cirrhosis, fatty liver disease and liver cancer.

Women need to measure indicators such as blood creatinine, electrolyte panel and urine analysis to assess kidney health. This testing aids in the detection of chronic kidney disease, acute renal failure and other kidney-related conditions.

Thyroid plays a crucial role in regulating metabolic processes, energy control and supporting the function of various organs in the body. Testing measures indicators such as TSH, FT3 and FT4 to detect thyroid dysfunction early. This is invaluable for preventing thyroid-related conditions, including hypothyroidism, hyperthyroidism and goiter.

Testing for sexually transmitted infections, including HIV, gonorrhea, syphilis, chlamydia, genital warts and HPV, is essential for comprehensive screening. These infections pose significant health risks to women if not detected and treated early.

Testing is especially important for pregnant women or those planning to conceive, as certain STDs, like HIV, gonorrhea, and syphilis, can be transmitted from mother to child, leading to serious complications in the fetus and even long-term effects after birth. Newborns may suffer from multi-organ damage and may experience developmental delays, affecting both mental and physical health.

Human papillomavirus (HPV) is the leading cause of cervical cancer, one of the most common and serious cancers affecting women. Symptoms of HPV infection in women include genital warts, pain, sores, or bleeding in the genital area. Without timely treatment, the infection can lead to severe health complications, including infertility.

HPV testing is crucial for women, especially those planning to conceive. Early detection of the virus allows for timely medical intervention to protect health and preserve fertility.

This antigen and antibody test is highly effective for screening HIV infection. It can be conducted as early as 3 - 12 weeks after exposure. For women planning to conceive, this test is essential to screen for HIV, reducing the risk of transmission to the child and enabling a healthier pregnancy.

Syphilis screening is essential for women, as this serious STD progresses through multiple stages and often presents no symptoms in the early phase. If left untreated until the late stages, syphilis can cause permanent damage to several organs, including the heart, brain, eyes, and nervous system.

This test is particularly crucial for pregnant women, as syphilis bacteria can be transmitted from mother to fetus, leading to congenital syphilis in newborns. Children with congenital syphilis often face severe complications affecting physical and cognitive development, with long-term impacts on their growth and health.

This is a vital group of tests for monitoring and evaluating physiological function to ensure women's fertility. Measuring hormone levels, including Progesterone, Estrogen, FSH and LH, assesses hormonal balance and detects issues such as menstrual disorders, infertility, or polycystic ovary syndrome. This reproductive health assessment is especially important for women planning to conceive or experiencing difficulties with conception.

Hormone testing also helps identify endocrine disorders, such as ovarian insufficiency or early menopause. If undiagnosed, these imbalances can have long-term impacts on overall health and fertility. Therefore, regular hormone testing is recommended to allow timely intervention and appropriate treatment.

AMH is an important hormone in women reflecting ovarian reserve. A higher ovarian reserve indicates better fertility potential, and vice versa. This test assesses a woman's fertility status and is especially useful for those planning future pregnancies, experiencing fertility challenges, or preparing for assisted reproductive techniques.

This test detects up to 40 strains of HPV causing cervical cancer, providing a comprehensive assessment of the risk of developing this cancer type. Additionally, it is used to screen for various HPV strains that can cause genital warts and other HPV-related conditions in women. Early HPV screening is essential for timely disease detection and can also aid in confirming cervical cancer status when abnormal Pap smear results are found.

The CA 15-3 test is highly valuable for monitoring and assessing the effectiveness of breast cancer treatment or detecting the risk of recurrence by identifying the breast cancer marker CA 15-3.

During treatment, physicians monitor CA 15-3 levels to evaluate the effectiveness of therapeutic approaches. If CA 15-3 levels decrease, it indicates that the treatment is working effectively. Conversely, if CA 15-3 levels increase, adjustments to the treatment plan may be needed to better manage the disease.

The test is commonly used for early detection of ovarian cancer risk by identifying the cancer marker CA 125. It also aids in monitoring ovarian cancer treatment and various other cancer types. CA 125 testing is valuable for checking for recurrence after the completion of treatment.

This comprehensive cancer screening is designed for early detection of common cancers in women, such as breast cancer, cervical cancer, ovarian cancer, and several others, even before symptoms become evident.

Screening is the most effective way to detect precancerous signs and allows for timely medical intervention, helping to prevent complications and reduce cancer-related mortality.

This test is optimized for a comprehensive assessment of osteoporosis. By analyzing key indicators such as creatinine, calcium, ALP, beta-crosslaps and vitamin D, women will have a clear overview of the bone health. This panel is also beneficial for evaluating broader bone-related health concerns.

Beta-Crosslaps is a biomarker for collagen breakdown in bones, often elevated in cases of osteoporosis. This test assesses bone metabolism, particularly the rate of bone resorption in the body.

In women, especially postmenopausal women with a high risk of osteoporosis due to hormonal changes, Beta-Crosslaps testing provides insights into bone health. This allows for early intervention to prevent osteoporosis, reduce fracture risk and support long-term bone health.

Rheumatoid Factor (RF) is an antibody associated with rheumatoid arthritis, a common autoimmune disease in women. Produced by the immune system, this antibody often targets the body’s joint tissues, leading to inflammation and joint pain.

RF testing is essential for women, especially those in middle age, to assess the risk of rheumatoid arthritis and other autoimmune conditions.

This test assesses deficiencies or excesses in essential vitamins and minerals such as vitamins B, D, magnesium and zinc. Imbalances in these levels can impact energy, mood and overall health in women.

This critical test group evaluates prolonged fatigue in women, as the thyroid plays an essential role in regulating metabolism and body energy levels. Thyroid dysfunction, such as hypothyroidism or hyperthyroidism, often results in persistent fatigue.

The test package measures key hormones such as TSH, T3, T4 to assess thyroid function, enabling early detection of thyroid disorders and supporting appropriate treatment. This helps alleviate prolonged fatigue and improves overall quality of life.

Cortisol is released in higher amounts when the body encounters stress. Measuring cortisol levels helps assess stress levels and their impact on overall health.